Abcam Plc (LON:ABC) declared a dividend on Monday, March 5th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, March 15th will be given a dividend of GBX 3.42 ($0.05) per share on Thursday, April 12th. This represents a dividend yield of 0.28%. The ex-dividend date is Thursday, March 15th. The official announcement can be seen at this link.
Abcam (LON ABC) remained flat at $GBX 1,241 ($17.15) during midday trading on Wednesday. 88,216 shares of the company traded hands, compared to its average volume of 437,821. Abcam has a 1-year low of GBX 9.73 ($0.13) and a 1-year high of GBX 1,290 ($17.82). The stock has a market capitalization of $2,540.00 and a P/E ratio of 4,279.31.
Several equities research analysts have weighed in on the stock. Peel Hunt restated a “hold” rating and issued a GBX 1,100 ($15.20) target price on shares of Abcam in a research note on Monday, January 22nd. Numis Securities upgraded shares of Abcam to a “buy” rating and set a GBX 1,200 ($16.58) target price for the company in a research note on Friday, January 5th. Berenberg Bank restated a “buy” rating and issued a GBX 1,240 ($17.13) target price on shares of Abcam in a research note on Friday, January 5th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a GBX 946 ($13.07) target price on shares of Abcam in a research note on Monday, January 8th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. Abcam presently has a consensus rating of “Hold” and an average target price of GBX 1,007.67 ($13.92).
TRADEMARK VIOLATION WARNING: This article was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://sportsperspectives.com/2018/03/14/abcam-plc-plans-dividend-of-gbx-3-42-abc.html.
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.